Abstract:Objective Radiotherapy, combined with surgical resection and chemotherapy, remains a first-line treatment for infiltrative gliomas. However, these tumor are not surgically curable, and often recur, even within the prior radiation field, and may demonstrate a more aggressive phenotype. We recently demonstrated that the radiated brain tumor microenvironment promotes tumor aggressiveness in an orthotopic patient-derived xenograft (PDX) model of glioblastoma (Mayo GBM 143). Importantly, high grade gliomas display diverse molecular phenotypes, and whether this genetic variability leads to divergent behaviour in the radiated tumor microenvironment is unknown. Herein, we characterize the effects of the irradiated brain microenvinroment on nine additional unique GBM cell lines to better understand the nuances of how tumor molecular phenotypes influence cellular dynamics. Methods Female athymic nude mice were randomly divided into cranial radiation (15 Gy) and non-radiated groups. Mice then underwent intracranial implantation with one of the selected PDX GBM cell lines (GBM 6, 10, 12, 39, 46, 76, 123, 164, 196; total n=8-15, per group, per line). GBM 6 cells were additionally implanted 6 months after completion of fractionated radiation (4Gy × 10 fractions or 2Gy × 30 fractions) vs sham radiation. Kaplan-Meyer (K-M) and log-rank tests were performed to compare the survival between irradiated and non-irradiated groups. Result Of nine previously untested human GBM lines, we found that five demonstrated shorter survival in the pre-radiated brain (GBM 6, 46, 76, 164, 196); similar to previous observations with GBM 143. GBM 6 was also evaluated 6 months after fractionated radiation yielding similar results. However, two lines yielded prolonged survival in the pre-radiated brain (GBM 10, 12); GBM12 and 10 demonstrated the fastest baseline growth in the non-radiated brain; GBM 39, 123 whose rate of growth was not impacted by the radiated brain, demonstrated a an intermediate baseline growth rate between that of those positively and negatively impacted by the radiated brain microenvironment. No other clinical or molecular phenotype was found to consistently correlate with response to the radiated microenvironment. Conclusion Among a total of 10 total human GBM lines evaluated to date, 60% induce faster mortality in a radiated microenvironment, and 20% induce slower mortality. These results highlight the likely critical impact of the irradiated microenvironment on tumor behaviour, yet illustrate that different tumors may exhibit opposing responses. Although further evaluation will be needed to understand mechanisms of divergent behavior, our data suggest the increased rate of growth in the radiated microenvironment may not apply to the fastest-growing tumor lines, which could instead demonstrate a paradoxical response.

Nimg-59. Comparative Analysis Of Long-Term Glioblastoma Survivors Using Machine Learning Generated Radio-Pathomic Metrics

Nimg-58. Machine Learning-Generated Whole-Brain Radio-Pathomic Tumor Probability Maps Within Contrast-Enhancement Stratify Survival In Glioblastoma Patients Undergoing Gross-Total Resection

Radt-38. Clinical, Molecular And Imaging Features Associated With Long Term Survival In Glioblastoma Patients

Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.

Radiomics-Based Machine Learning with Natural Gradient Boosting for Continuous Survival Prediction in Glioblastoma

Radiomics for Survival Analysis and Prediction in Glioblastoma (GBM)—A Preliminary Study

Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation

Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma

Comparison of MRI Radiomics-Based Machine Learning Survival Models in Predicting Prognosis of Glioblastoma Multiforme

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Optimizing Glioblastoma, IDH-wildtype Treatment Outcomes : A Radiomics and Support Vector Machine -Based Approach to Overall Survival Estimation

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme

Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance

Deciphering the Glioblastoma Phenotype by Computed Tomography Radiomics.

Biom-27. Voxel-Wise Survival Analysis In Glioblastoma: Tumor Probability Maps Reveal Critical Regions Near White Matter Tracts

AB047. Searching for Factors Relating to Long-Term Survivors of Glioblastoma

Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.

Glioblastoma and Radiotherapy: a multi-center AI study for Survival Predictions from MRI (GRASP study)

Nimg-75. Similarity Distances-Based Delta Radiomics (Sddr) Enables Longitudinal Mri Comparisons For Survival Prediction In Gliomas: A Multi-Institutional Validation

Impact of the Radiated Brain Microenvironment on a Panel of Human Patient-Derived Xenografts

NIMG-23. COMPARISON OF A RADIO-PATHOMIC MODEL VERSUS A RADIOLOGY-ONLY TUMOR SEGMENTATION MODEL FOR THE DETECTION OF INFILTRATIVE TUMOR IN GLIOMA PATIENTS